Flora Peyvandi Shares BIC 2025 Coverage of Hemostasis & Thrombosis: 10 Posts Not To Miss
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X:
Flora Peyvandi shared BIC 2025 Coverage of latest research on Hemostasis and Thrombosis fresh from the conference:
1.‘‘Wolfgang Miesbach reports the safety of HA and HB gene therapies after 5 and 4 years respectively”

2.”David Lilicrap reports the interindividual variability of gene therapy in Hemophilia at BIC2025”

3.‘‘David Lilicrap reports data on long term safety of HA gene therapy”

4.”Alessio Cantore at Bic 2025 reporting where we are standing with lentiviral gene therapy in Hemophilia”

5.”Naldini group showed clearly they are ready to go through clinical trial phase 1 for HB with lenti viral vector and what’s missing is Funding.
Why that’s happening? No more interest in GT in Hemophilia even for the cure?”

6.”Very interesting data on gene therapy as the ITI to reverse the anti factor inhibitors in mice with anti FIX inhibitors was successful bic 2025.
Data from Dr Herzog Indiana University”

7.”New gene therapy clinical trial on FVII severe deficiency by Amit Nathwani. Look forward for that!”

8.”Amy Shapiro reports a new DDAP molecule to treat patients with VWD type 1.
This is a great news due to discontinuation of intranasal Desmopressin and it shortage.
This formulation is available in US”

9.”A single dose of VGA039 in 10 patients with VWD inhibiting PS , showed good efficacy with no safety issue reported by Carolyn Millar”

10.”Michela Milani should how they created a shielded lentiviral vector to reduce the immunogenicity against FVIII in mice”

More from BIC 2025 featured in Hemostasis Today.
-
Oct 31, 2025, 14:17When Stories Save Lives: Reza Shojaei Shares Blood and Plasma Pulse Newest Issue
-
Oct 31, 2025, 13:34Charlotte Pilling Invites You to ''Women in Hematology'' US Focus Meeting
-
Oct 30, 2025, 12:12Laura Ceci Galanos Reflects on WSC 2025
-
Oct 30, 2025, 07:56Vallabh Janardhan: Strokes Affecting Younger Patients
-
Oct 30, 2025, 07:55“Marrow Asleep or Awake?”: William Aird Simplifies Anemia Diagnosis
-
Oct 31, 2025, 13:47Bethany Brown and Colleagues Present Recommendations on DEHP Alternatives
-
Oct 30, 2025, 07:52Haemophilia B - An illustrative review of current challenges and opportunities
-
Oct 30, 2025, 05:14Umberto Pensato on Reperfusion Outcomes in Stroke
-
Oct 29, 2025, 07:39Pablo Corral: Pushing the Limits of LDLc: Emerging Paradigms in CV Risk Reduction
-
Oct 29, 2025, 07:38Thijs van Haaps and Team Show That Andexanet Alfa May Go Beyond Apixaban and Rivaroxaban
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Oct 31, 2025, 14:41Emilya Huseynova Reflects on AABB 2025
-
Oct 31, 2025, 14:33Cihan Ay Delivers Seminar at McMaster University on Thrombosis Research
-
Oct 31, 2025, 14:25Thomas Reiser Steps Down as ISTH Executive Director After 14+ Years of Leadership
-
Oct 31, 2025, 14:02Murray Adams Reflects on His Week Attending Blood 2025
-
Oct 31, 2025, 13:10Angelique Balguid: World Stroke Day is More Than a Moment — It’s a Movement
